In brief

BMJ 2005; 331 doi: 10.1136/bmj.331.7516.532 (Published 8 September 2005)
Cite this as: BMJ 2005;331:532.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

WHO says monitor resistance to new malaria drugs: Countries have been urged by the World Health Organization to monitor closely the effectiveness of artemisinin based combination therapies, the recommended treatment option for countries where resistance to standard malaria drugs is a problem. See http://www.who.int/

Neglected disease research threatened: Public-private partnerships have been a critical driver of research into …

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL